#326 CSA vs. CSV: Modern Validation for Modern MedTech

Global Medical Device Podcast · 7 Jul 2023 · 1h 08m · Episode 326

What this episode covers

Sandra Rodriguez, an analyst at Axendia, discusses the FDA's shift from Computer System Validation (CSV) to Computer Software Assurance (CSA) in medical device manufacturing. She explains how CSA flips the traditional validation pyramid by prioritizing critical thinking and risk assessment over exhaustive documentation, significantly reducing the burden on companies. The conversation covers the industry's response to the September 2022 draft guidance, the role of GAMP 5, and the evolving relationship between life science companies and technology vendors like Greenlight Guru.

Mentioned

Companies
Axendia, Greenlight Guru, FDA, Boston Scientific, Edwards Life Sciences, Baxter, MDIC
Also
GAMP 5, Case for Quality, ISO 13485, ISO 14971, 21 CFR Part 11

Other shows on the same ground, closest first.

  • Let's Combinate · 44m

    090 - Software Validation, Automation, No-Code Quality Tools and QMS with Harsh Thakkar

    Harsh Thakkar, CEO of Qualtivate, explains how life sciences companies can automate quality management systems (QMS) using no-code tools like Zapier and Make to reduce manual reporting burdens. He details the regulatory framework for software validation, distinguishing between out-of-the-box, configured, and custom software categories defined in GAMP 5. Thakkar emphasizes that validation should focus on intended use and risk rather than validating the entire system, citing the FDA's Computer Software Assurance (CSA) guidance as a way to reduce documentation burdens.

  • The Pragmatic Embedded Podcast · 33m

    How to Speed Up Safety Critical Processes

    Jeff Gable and Luca Njani discuss strategies to accelerate safety-critical development in medical devices, automotive, and aerospace without compromising quality. They argue that reducing scope for initial releases and automating documentation using modern tools like Jama and Matrix significantly shortens cycle times. The hosts emphasize that modern regulatory guidance, such as the FDA's Computer System Assurance, supports streamlined validation processes, allowing teams to iterate faster and uncover defects earlier.

  • Let's Combinate · 1h 13m

    010 - "Don't Make Assumptions" with David Simoens

    David Simoens, COO of cGMP Consulting Group, explains how a risk-based approach can streamline commissioning, qualification, and validation (C&Q) in pharmaceutical manufacturing. He details the transition from traditional, repetitive testing to leveraging data from Factory Acceptance Tests (FAT) and Site Acceptance Tests (SAT) through rigorous User Requirement Specifications (URS) and risk assessments. Simoens highlights common pitfalls, such as poorly written 70-page URS documents and inadequate debugging at the vendor site, which lead to significant project delays and cost overruns. He emphasizes the importance of using tools like FMEA and ISPE guidelines to identify critical aspects early, ensuring that testing is performed once and leveraged through to Performance Qualification (PQ).

  • Let's Combinate · 41m

    134 - ISO62304, Software Development Process, SaMD, Closed Loop Systems, Complexities with Cloud and Better Software in MedTech with Richard Koch

    Richard Koch, founder of KochSaMD, explains the complexities of developing cloud-based medical devices, using a closed-loop insulin pump system as a primary case study. He details how ISO 62304 governs software development within the broader ISO 13485 framework, emphasizing the shift from batch-based physical manufacturing to continuous, high-velocity software updates. Koch warns that tech giants like Apple and Google are disrupting the industry by leveraging their digital expertise to acquire or compete with traditional medtech firms, urging leaders to upskill in software development to survive.

  • Let's Combinate · 52m

    128 - Former FDA Inspector and Managing Consultant, Vin Cafiso: Cadavers/Autopsies, Tales from FDA Inspections, Understanding the QMSR, and Quality Culture

    Vin Cafiso, former FDA Consumer Safety Officer and Managing Consultant at Practical Compliance Results, discusses the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR) and its impact on small medical device companies. He explains how FDA inspection methodologies are shifting from issue-focused 483s to process-based QSET audits, emphasizing the importance of understanding quality culture through simple engagement rather than rigid metrics. Cafiso shares insights from his career at companies like BD and Smith & Nephew, highlighting how starting as an investigator builds a strong foundation for industry roles by providing a broad view of quality systems across diverse products and company sizes.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.